Outcome Measures: |
Primary: Maximum change in hemoglobin by Week 9 from baseline, Week 9 | Secondary: Proportion of subjects achieving a target Hb level ≥11 g/dL by Weeks 5,6,7,8 and 9., Week 9|Proportion of subjects with a Hb increase from baseline ≥1.0 g/dL., Week 9
|
Locations: |
Peking Union Medical College Hospital, Beijing, China|Peking University First Hospital, Beijing, China|Sichuan Provincial People's Hospital, Chengdu, China|West China Hospital, Chengdu, China|First affiliated hospital of Dalian medical university, DaLian, China|First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China|Zhejiang University No 1. Hospital, Hangzhou, China|Chang Zheng Hospital, Shanghai, China|Huashan Hospital, Shanghai, China|Renji Hospital, Shanghai, China|RuiJin Hospital, Shanghai, China|XinHua Hospital, Shanghai, China|Shenzhen People's Hospital, Shenzhen, China
|